A study to be published in an upcoming edition of the journal of Cardiovascular Toxicology reveals Pycnogenol natural pine bark extract from the French maritime pine tree, helps prevent damage that high blood pressure causes to the heart.
More than 1,000 researchers, clinicians and mental health advocates are expected to attend the Seventh International Conference on Bipolar Disorder, June 7-9 at the David L. Lawrence Convention Center in Pittsburgh.
Tropical deforestation is the source of nearly a fifth of annual, human-induced emissions of heat-trapping gases to the atmosphere. Recent studies by Woods Hole Research Center scientists demonstrate that during years of severe drought, tropical rainforest fires can double emissions from tropical forests.
What did the Vikings eat for supper? How good were the grocers in Roman Pompeii? What was it like feasting with the Greeks in the second millennium BC? How can this tell us why we like TV dinners today?
The translation of important results of clinical research into consistent benefits for patients is of special interest to Emergency Medicine and will be the subject of the 2007 Academic Emergency Medicine Consensus Conference.
Governor Jim Doyle gave a $1 million boost to a University of Wisconsin-Madison spin-off company during a visit to the campus lab that gave birth to its technology.
The Honourable Tony Clement, Minister of Health, congratulated three recipients of the Award of Excellence in Nursing for nurses working in First Nations and Inuit communities. The ceremony, held during National Nursing Week, took place at the Government Conference Centre in Ottawa.
Boston Scientific Corporation (NYSE: BSX) commented on data released on May 9th at the American Association for Thoracic Surgery (AATS) conference in Washington, D.C. Dudley A. Hudspeth, M.D., of Desert Cardiothoracic Surgeons in Mesa, Arizona, reported positive results from his single-center clinical investigation of 79 patients treated with the FLEX 10? and FLEX 10? XE Microwave Ablation Probes.
The antiviral drug peramivir might offer humans significant protection during a pandemic of the avian influenza virus H5N1, according to results of mouse studies conducted by investigators at St. Jude Children’s Research Hospital.
IDM Pharma, Inc. (NASDAQ: IDMI) announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to 2 that the results of INT 0133, the Phase 3 trial, do not provide substantial evidence of effectiveness of Junovan (mifamurtide) in the treatment of patients with non-metastatic, resectable osteosarcoma receiving combination chemotherapy.